Fundamentals data is not available for this company.
Year Ending | Revenue ($m) | Pre-tax ($m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
---|---|---|---|---|---|---|---|---|
31-Dec-25 | 34.12 | (595.78) | (617.66)¢ | n/a | n/a | n/a | n/a | 0.0% |
31-Dec-26 | 152.93 | (418.46) | (422.84)¢ | n/a | n/a | n/a | n/a | 0.0% |
31-Dec-27 | 330.10 | (333.30) | (334.88)¢ | n/a | n/a | n/a | n/a | 0.0% |
Copyright © 2025 FactSet Research Systems Inc. All rights reserved.
MaxCyte signs cell platform deal with CRISPR and... | 14-Mar-2017 | ShareCast |
Currency | US Dollars |
Share Price | $ 59.07 |
Change Today | $ -2.12 |
% Change | -3.46 % |
52 Week High | $61.75 |
52 Week Low | $57.80 |
Volume | 2,768,291 |
Shares Issued | 47.19m |
Market Cap | $2,787.68m |
RiskGrade | 311 |
Strong Buy | 6 |
Buy | 10 |
Neutral | 11 |
Sell | 2 |
Strong Sell | 0 |
Total | 29 |
Time | Volume / Share Price |
16:00 | 154,671 @ $59.07 |
15:59 | 100 @ $59.07 |
15:59 | 100 @ $59.07 |
15:59 | 200 @ $59.07 |
15:59 | 100 @ $59.07 |
You are here: research